Anti-inflammatory therapeutics are prescription drugs designed to address pain, reduce inflammation, and lower elevated body temperatures. They function as modifiers of the body's immune response and are essential in the management of both acute and chronic conditions such as headaches, painful episodes, as well as sprains and strains.
The primary categories of drug classes used in anti-inflammatory therapeutics encompass nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and anti-inflammatory biologics. Nonsteroidal anti-inflammatory drugs are analgesic medications without opioids that are commonly employed by individuals to alleviate mild physical discomfort. These medications find diverse applications in conditions like arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel diseases, and more. They are available through a range of distribution channels, including retail pharmacies, hospital pharmacies, and online retail platforms.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The anti-inflammatory therapeutics market research report is one of a series of new reports from The Business Research Company that provides anti-inflammatory therapeutics market statistics, including anti-inflammatory therapeutics industry global market size, regional shares, competitors with an anti-inflammatory therapeutics market share, detailed anti-inflammatory therapeutics market segments, market trends and opportunities and any further data you may need to thrive in the anti-inflammatory therapeutics industry. These anti-inflammatory therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $114.71 billion in 2024 to $117.28 billion in 2025 at a compound annual growth rate (CAGR) of 2.2%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives.
The anti-inflammatory therapeutics market size is expected to see steady growth in the next few years. It will grow to $142.15 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications.
The forecast of 4.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. rheumatology centers by increasing the cost of biologic disease-modifying antirheumatic drugs like adalimumab biosimilars sourced from South Korea and Switzerland, thereby limiting autoimmune disease treatment accessibility and elevating specialty drug expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing incidence of inflammatory bowel disease is set to drive the expansion of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics play a pivotal role in the treatment of conditions like Crohn's disease, as they help reduce inflammation, manage symptoms, and lower the likelihood of surgery. For example, a July 2023 report from Oxford University Press (OUP), the university press of the University of Oxford, indicates that IBD has an incidence of 10.9 per 100,000 person-years and a prevalence of 721 per 100,000 people. Consequently, the rising prevalence of inflammatory bowel disease is a significant driver of growth in the anti-inflammatory therapeutics market.
The increasing prevalence of autoimmune disorders is expected to drive the expansion of the anti-inflammatory therapeutics market in the future. Autoimmune disorders encompass a group of medical conditions where the body's immune system, typically responsible for defending against harmful invaders like bacteria and viruses, erroneously targets and attacks the body's own healthy cells and tissues. The growing prevalence of autoimmune disorders plays a significant role in the increasing demand for anti-inflammatory therapeutics. These therapeutics are frequently employed in the treatment of autoimmune disorders, aiming to reduce inflammation, regulate the overactive immune response, and alleviate the symptoms associated with these conditions. For instance, as reported in January 2022 by the Guardian Media Group, a UK-based media company, it is anticipated that there will be 4 million people in the UK suffering from autoimmune disorders, with a global increase estimated at 3% to 9% annually. Additionally, data from May 2023 from the University of Oxford, a UK-based research university, indicates that autoimmune disorders affect 10% of the world's population. Consequently, the rising prevalence of autoimmune disorders is a driving force behind the growth of the anti-inflammatory therapeutics market.
Prominent companies within the anti-inflammatory therapeutics market are actively introducing innovative drugs as a strategy to enhance their market presence. As an example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, jointly introduced Kevzara (sarilumab). This represents the first and only anti-inflammatory biologic designed for adult patients dealing with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition. It is particularly targeted at individuals who either do not respond adequately to corticosteroids or cannot tolerate corticosteroid tapering.
In March 2022, Pfizer Inc., a US-based biopharmaceutical company, completed a $6.7 billion acquisition of Arena Pharmaceuticals. This strategic move by Pfizer is intended to enhance its portfolio in the field of inflammation and immunology therapeutics, with a focus on conditions such as ulcerative colitis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. Arena Pharmaceuticals, a US-based company, specializes in the development of diverse anti-inflammatory drugs for the treatment of various immuno-inflammatory disorders.
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the anti-inflammatory therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The anti-inflammatory therapeutics market consists of sales of Ibuprofen, naproxen, and diclofenac. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anti-Inflammatory Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anti-inflammatory therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anti-inflammatory therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-inflammatory therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Anti-Inflammatory Biologics
- 2) By Indication: Arthritis; Respiratory Diseases; Multiple Sclerosis; Psoriasis; Inflammatory Bowel Diseases; Other Inflammatory Diseases
- 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Distribution
- Subsegments:
- 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Aspirin; Naproxen; Diclofenac; Celecoxib; Indomethacin; Ketoprofen
- 2) By Corticosteroids: Prednisone; Dexamethasone; Hydrocortisone; Methylprednisolone; Triamcinolone; Betamethasone
- 3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors; Janus Kinase (JAK) Inhibitors; Monoclonal Antibodies; Recombinant Proteins; Fusion Proteins
- Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; F. Hoffmann-La Roche Ltd.; Merck and Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi-Aventis LLC.; Bristol-Myers Squibb Company; AstraZeneca PLC; GlaxoSmithKline plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Co Ltd.; Amgen Inc.; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Biogen Inc.; Daiichi Sankyo Company Limited; Eisai Co. Ltd.; Sun Pharmaceutical Industries Limited; Otsuka Pharmaceutical Co. Ltd.; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals PLC; Cipla Inc.; Zydus Lifesciences Ltd.; Lupin Limited; Torrent Pharmaceuticals Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anti-Inflammatory Therapeutics Market Characteristics
3. Anti-Inflammatory Therapeutics Market Trends And Strategies
4. Anti-Inflammatory Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Anti-Inflammatory Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Anti-Inflammatory Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Anti-Inflammatory Therapeutics Market Growth Rate Analysis
- 5.4. Global Anti-Inflammatory Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Anti-Inflammatory Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Anti-Inflammatory Therapeutics Total Addressable Market (TAM)
6. Anti-Inflammatory Therapeutics Market Segmentation
- 6.1. Global Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
- Anti-Inflammatory Biologics
- 6.2. Global Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Arthritis
- Respiratory Diseases
- Multiple Sclerosis
- Psoriasis
- Inflammatory Bowel Diseases
- Other Inflammatory Diseases
- 6.3. Global Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Retail Pharmacies
- Hospital Pharmacies
- Online Distribution
- 6.4. Global Anti-Inflammatory Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ibuprofen
- Aspirin
- Naproxen
- Diclofenac
- Celecoxib
- Indomethacin
- Ketoprofen
- 6.5. Global Anti-Inflammatory Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prednisone
- Dexamethasone
- Hydrocortisone
- Methylprednisolone
- Triamcinolone
- Betamethasone
- 6.6. Global Anti-Inflammatory Therapeutics Market, Sub-Segmentation Of Anti-Inflammatory Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tumor Necrosis Factor (TNF) Inhibitors
- Interleukin Inhibitors
- Janus Kinase (JAK) Inhibitors
- Monoclonal Antibodies
- Recombinant Proteins
- Fusion Proteins
7. Anti-Inflammatory Therapeutics Market Regional And Country Analysis
- 7.1. Global Anti-Inflammatory Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Anti-Inflammatory Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Anti-Inflammatory Therapeutics Market
- 8.1. Asia-Pacific Anti-Inflammatory Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anti-Inflammatory Therapeutics Market
- 9.1. China Anti-Inflammatory Therapeutics Market Overview
- 9.2. China Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anti-Inflammatory Therapeutics Market
- 10.1. India Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anti-Inflammatory Therapeutics Market
- 11.1. Japan Anti-Inflammatory Therapeutics Market Overview
- 11.2. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anti-Inflammatory Therapeutics Market
- 12.1. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anti-Inflammatory Therapeutics Market
- 13.1. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anti-Inflammatory Therapeutics Market
- 14.1. South Korea Anti-Inflammatory Therapeutics Market Overview
- 14.2. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anti-Inflammatory Therapeutics Market
- 15.1. Western Europe Anti-Inflammatory Therapeutics Market Overview
- 15.2. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anti-Inflammatory Therapeutics Market
- 16.1. UK Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anti-Inflammatory Therapeutics Market
- 17.1. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anti-Inflammatory Therapeutics Market
- 18.1. France Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anti-Inflammatory Therapeutics Market
- 19.1. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anti-Inflammatory Therapeutics Market
- 20.1. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anti-Inflammatory Therapeutics Market
- 21.1. Eastern Europe Anti-Inflammatory Therapeutics Market Overview
- 21.2. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anti-Inflammatory Therapeutics Market
- 22.1. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anti-Inflammatory Therapeutics Market
- 23.1. North America Anti-Inflammatory Therapeutics Market Overview
- 23.2. North America Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anti-Inflammatory Therapeutics Market
- 24.1. USA Anti-Inflammatory Therapeutics Market Overview
- 24.2. USA Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Anti-Inflammatory Therapeutics Market
- 25.1. Canada Anti-Inflammatory Therapeutics Market Overview
- 25.2. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anti-Inflammatory Therapeutics Market
- 26.1. South America Anti-Inflammatory Therapeutics Market Overview
- 26.2. South America Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anti-Inflammatory Therapeutics Market
- 27.1. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anti-Inflammatory Therapeutics Market
- 28.1. Middle East Anti-Inflammatory Therapeutics Market Overview
- 28.2. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anti-Inflammatory Therapeutics Market
- 29.1. Africa Anti-Inflammatory Therapeutics Market Overview
- 29.2. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anti-Inflammatory Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Anti-Inflammatory Therapeutics Market Competitive Landscape
- 30.2. Anti-Inflammatory Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Anti-Inflammatory Therapeutics Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Novartis AG
- 31.3. Sanofi-Aventis LLC.
- 31.4. Bristol-Myers Squibb Company
- 31.5. AstraZeneca PLC
- 31.6. GlaxoSmithKline plc.
- 31.7. Takeda Pharmaceutical Company Limited
- 31.8. Eli Lilly and Co Ltd.
- 31.9. Amgen Inc.
- 31.10. Boehringer Ingelheim International GmbH
- 31.11. Viatris Inc.
- 31.12. Teva Pharmaceutical Industries Ltd.
- 31.13. Regeneron Pharmaceuticals Inc.
- 31.14. Astellas Pharma Inc.
- 31.15. Biogen Inc.
32. Global Anti-Inflammatory Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Anti-Inflammatory Therapeutics Market
34. Recent Developments In The Anti-Inflammatory Therapeutics Market
35. Anti-Inflammatory Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Anti-Inflammatory Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Anti-Inflammatory Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Anti-Inflammatory Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
